CT
NVS icon

Caldwell Trust’s Novartis NVS Stock Holding History

Caldwell Trust’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
2,167
-143
-6% -$21.4K 0.03% 272
2026
Q1 		$353K Hold
2,310
– – 0.03% 263
2025
Q4 		$318K Sell
2,310
-618
-21% -$80.9K 0.03% 271
2025
Q3 		$375K Sell
2,928
-199
-6% -$24.3K 0.04% 250
2025
Q2 		$378K Sell
3,127
-140
-4% -$15.8K 0.04% 245
2025
Q1 		$364K Sell
3,267
-63
-2% -$6.71K 0.04% 245
2024
Q4 		$324K Hold
3,330
– – 0.03% 258
2024
Q3 		$383K Hold
3,330
– – 0.04% 245
2024
Q2 		$355K Sell
3,330
-100
-3% -$10K 0.04% 246
2024
Q1 		$332K Hold
3,430
– – 0.04% 252
2023
Q4 		$346K Sell
3,430
-325
-9% -$31.4K 0.04% 239
2023
Q3 		$382K Hold
3,755
– – 0.05% 223
2023
Q2 		$379K Hold
3,755
– – 0.05% 225
2023
Q1 		$345K Sell
3,755
-250
-6% -$21.8K 0.05% 230
2022
Q4 		$363K Sell
4,005
-1,165
-23% -$98.1K 0.05% 219
2022
Q3 		$393K Sell
5,170
-1
-0% -$83 0.06% 207
2022
Q2 		$437K Sell
5,171
-255
-5% -$22.4K 0.06% 202
2022
Q1 		$476K Sell
5,426
-127
-2% -$11K 0.06% 207
2021
Q4 		$486K Sell
5,553
-508
-8% -$42.2K 0.06% 210
2021
Q3 		$496K Sell
6,061
-131
-2% -$11.8K 0.06% 205
2021
Q2 		$565K Sell
6,192
-230
-4% -$20.5K 0.07% 179
2021
Q1 		$549K Sell
6,422
-598
-9% -$53.7K 0.08% 178
2020
Q4 		$663K Sell
7,020
-144
-2% -$12.6K 0.1% 147
2020
Q3 		$623K Sell
7,164
-220
-3% -$19.1K 0.1% 141
2020
Q2 		$645K Sell
7,384
-225
-3% -$19.4K 0.11% 143
2020
Q1 		$627K Sell
7,609
-606
-7% -$54.1K 0.12% 133
2019
Q4 		$778K Buy
+8,215
New +$737K 0.12% 141

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Caldwell Trust's NVS Position: Q2 2026 in Review

Caldwell Trust reduced its Novartis (NVS) stake by 6.2% in Q2 2026, selling an estimated $21.4K and leaving 2,167 shares worth $340K. The position accounts for 0.03% of the portfolio, ranked #272.

Caldwell Trust first reported a position in NVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $778K in Q4 2019. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Caldwell Trust held 2,167 shares of Novartis worth $340K as of Q2 2026.
  • Caldwell Trust sold 143 Novartis shares in Q2 2026, an estimated $21.4K.
  • Novartis made up 0.03% of Caldwell Trust's portfolio in Q2 2026, its #272 holding.
  • Caldwell Trust first reported a position in Novartis in Q4 2019 and has held it in 27 quarters since.
  • Caldwell Trust's Novartis position peaked at $778K in Q4 2019.
  • 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.